Director/PDMR Shareholding
17 September 2026
Genus plc
Director/PDMR Shareholding
Genus plc (LSE: GNS) announces that on 16 September 2026, conditional share awards were granted under the Genus 2025 Long Term Incentive Plan ('LTIP') over ordinary shares in Genus to the Executive Directors and members of the Genus Executive Leadership Team ('GELT'). Awards granted as performance share units ('PSUs') are listed in table A below; Awards granted as restricted share units ('RSUs') are listed in table B below. In addition, in line with Genus' deferral requirements relating to the annual bonus earned by Executive Directors and GELT for the financial year ended 30 June 2026, conditional share awards were granted over ordinary shares under the Genus 2025 Deferred Bonus Plan ('DBP') as listed in table C below.
Details of the performance conditions that apply to the PSUs can be found in the Directors' Remuneration Report of the Genus 2026 Annual Report which will be published next month.
The price at which LTIP and DBP share awards have been granted was determined in accordance with the LTIP and DBP rules.
The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail of the conditional awards made on 16 September 2026.
For further information please contact:
Genus:
Vaughn Walton, Deputy Company Secretary Tel: +44 (0)1256 347100
Table A - GELT 2025 Long Term Incentive Plan Awards - PSUs
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||||||||||||
|
a. |
Name |
1. Jorgen Kokke 2. Andy Russell 3. Mark Birri 4. Matt Culbertson 5. Jim Low 6. Elena Rice 7. Angelle Rosata 8. Lucie Grant |
||||||||||||||||||
|
2. |
Reason for the notification |
|||||||||||||||||||
|
a. |
Position/status |
1. Chief Executive Officer 2. Chief Financial Officer 3. Chief Corporate Development Officer 4. Chief Operating Officer Genus PIC 5. Chief Operating Officer Genus ABS 6. Chief Scientific Officer 7. Chief Human Resources Officer 8. Group General Counsel & Company Secretary |
||||||||||||||||||
|
b. |
Initial notification /Amendment
|
Initial notification |
||||||||||||||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||||||||
|
a. |
Name |
Genus plc |
||||||||||||||||||
|
b. |
LEI |
54930022EOITNKSIGH56 |
||||||||||||||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||||||||
|
a. |
Description of the Financial instrument, type of instrument Identification code |
Ordinary shares of 10p each.
GB0002074580 |
||||||||||||||||||
|
b. |
Nature of the transaction |
Conditional award granted as PSUs under the LTIP over ordinary shares in Genus.
|
||||||||||||||||||
|
c. |
Price(s) and volume(s) |
Numbers 1 to 8 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
|
||||||||||||||||||
|
d. |
Aggregated information · Aggregated volume · Price
|
n/a
|
||||||||||||||||||
|
e. |
Date of the transaction |
2026-09-16 |
||||||||||||||||||
|
f. |
Place of the transaction |
Outside a trading venue.
|
||||||||||||||||||
Table B - GELT 2025 Long Term Incentive Plan Awards - RSUs
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||||||||||||
|
a. |
Name |
1. Jorgen Kokke 2. Andy Russell 3. Mark Birri 4. Matt Culbertson 5. Jim Low 6. Elena Rice 7. Angelle Rosata 8. Lucie Grant |
||||||||||||||||||
|
2. |
Reason for the notification |
|||||||||||||||||||
|
a. |
Position/status |
1. Chief Executive Officer 2. Chief Financial Officer 3. Chief Corporate Development Officer 4. Chief Operating Officer Genus PIC 5. Chief Operating Officer Genus ABS 6. Chief Scientific Officer 7. Chief Human Resources Officer 8. Group General Counsel & Company Secretary |
||||||||||||||||||
|
b. |
Initial notification /Amendment
|
Initial notification |
||||||||||||||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||||||||
|
a. |
Name |
Genus plc |
||||||||||||||||||
|
b. |
LEI |
54930022EOITNKSIGH56 |
||||||||||||||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||||||||
|
a. |
Description of the Financial instrument, type of instrument Identification code |
Ordinary shares of 10p each.
GB0002074580 |
||||||||||||||||||
|
b. |
Nature of the transaction |
Conditional award granted as RSUs under the LTIP over ordinary shares in Genus.
|
||||||||||||||||||
|
c. |
Price(s) and volume(s) |
Numbers 1 to 8 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
|
||||||||||||||||||
|
d. |
Aggregated information · Aggregated volume · Price
|
n/a
|
||||||||||||||||||
|
e. |
Date of the transaction |
2026-09-16 |
||||||||||||||||||
|
f. |
Place of the transaction |
Outside a trading venue.
|
||||||||||||||||||
Table C - GELT 2025 Deferred Bonus Plan Awards
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||||||||||
|
a. |
Name |
1. Jorgen Kokke 2. Andy Russell 3. Mark Birri 4. Matt Culbertson 5. Jim Low 6. Elena Rice 7. Lucie Grant |
||||||||||||||||
|
2. |
Reason for the notification |
|||||||||||||||||
|
a. |
Position/status |
1. Chief Executive Officer 2. Chief Financial Officer 3. Chief Corporate Development Officer 4. Chief Operating Officer Genus PIC 5. Chief Operating Officer Genus ABS 6. Chief Scientific Officer 7. Group General Counsel & Company Secretary |
||||||||||||||||
|
b. |
Initial notification /Amendment |
Initial notification |
||||||||||||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||||||
|
a. |
Name |
Genus plc |
||||||||||||||||
|
b. |
LEI |
54930022EOITNKSIGH56 |
||||||||||||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||||||
|
a. |
Description of the Financial instrument, type of instrument Identification code |
Ordinary shares of 10p each.
GB0002074580 |
||||||||||||||||
|
b. |
Nature of the transaction |
Conditional award granted under the DBP over ordinary shares in Genus.
|
||||||||||||||||
|
c. |
Price(s) and volume(s) |
Numbers 1 to 7 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
|
||||||||||||||||
|
d. |
Aggregated information · Aggregated volume · Price
|
n/a |
||||||||||||||||
|
e. |
Date of the transaction |
2026-09-16
|
||||||||||||||||
|
f. |
Place of the transaction |
Outside a trading venue.
|
||||||||||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE